Current Neuro-Oncology
Volume
11 Number 3
31 March 2009
Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 3, 31 March
Edvardsson TI, Ahlström GI.
Subjective quality of life
in persons with low-grade glioma and their next of kin.
Int
J Rehabil Res. 2009 Mar;32(1):64-70. doi:
10.1097/MRR.0b013e32830bfa8c. PMID:
19648803. Observational study. ˍ
Erpolat OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber
S.
Outcome of newly diagnosed
glioblastoma patients treated by radiotherapy plus concomitant and
adjuvant temozolomide: a long-term analysis.
Tumori.
2009 Mar-Apr;95(2):191-7. doi:
10.1177/030089160909500210. PMID:
19579865. Observational study. ˍ
Fares Y, Younes M, Kanj A, Barnes PR, Muñiz J.
Multicentric
glioma: problems & interpretations. [corrected].
P
R Health Sci J. 2009 Mar;28(1):75-9. PMID:
19266744. Case report. ˍ
Erratum in: P R Health Sci J. 2011 Sep;30(3):162.
*
Frank S, Kuhn SA, Brodhun M, Mueller U, Romeike B, Kosmehl H,
Regenbrecht CR, Ewald C, Reichart R, Kalff R.
Metastatic
glioblastoma cells use common pathways via blood and lymphatic
vessels.
Neurol
Neurochir Pol. 2009 Mar-Apr;43(2):183-90. PMID:
19484696. Case report. ˍ
*
Ho LT, Wassef H, Henderson R, Seto
J.
F-18
FDG PET-CT imaging in recurrent cerebral gliosarcoma.
Clin
Nucl Med. 2009
Mar;34(3):153-4. doi:
10.1097/RLU.0b013e3181966fc6. PMID:
19352277. Case report. ˍ
Teixeira MJ, Fonoff ET, Mandel M,
Alves HL, Rosemberg S.
Stereotactic
biopsies of brain lesions.
Arq
Neuropsiquiatr.
2009 Mar;67(1):74-7. doi:
10.1590/s0004-282x2009000100018. PMID:
19330216. Observational
study. ˍ
Oshiro S, Tsugu H, Komatsu F,
Ohmura T, Ohta M, Sakamoto S, Fukushima T, Inoue T.
Efficacy
of temozolomide treatment in patients with high-grade
glioma.
Anticancer
Res. 2009 Mar
1;29(3):911-7. PMID:
19414327. Observational
study. ˍ
Pirotte BJ, Levivier M, Goldman S, Massager N, Wikler D, Dewitte
O, Bruneau M, Rorive S, David P, Brotchi J.
Positron
emission tomography-guided volumetric resection of supratentorial
high-grade gliomas: a survival analysis in 66 consecutive
patients.
Neurosurgery.
2009 Mar 1;64(3):471-81. doi:
10.1227/01.NEU.0000338949.94496.85. PMID:
19240609. Observational
study. ˍ
Chamberlain MC.
Cilengitide:
does it really represent a new targeted therapy
for
recurrent glioblastoma?
J
Clin Oncol. 2009
Mar 2;27(11):1921. doi:
10.1200/JCO.2008.21.5871. PMID:
19255301. Comment. ˍ
Related
article:
Reardon
DA, Fink KL, Mikkelsen T, et al. Randomized
phase II study of
cilengitide,
an integrin-targeting arginine-glycine-aspartic acid peptide, in
recurrent
glioblastoma multiforme. J
Clin Oncol.
2008 Nov
3;26(34):5610-7.
doi:
10.1200/JCO.2008.16.7510.
PMID:
18981465. Interventional study. ˍ
Pfister S, Remke M, Benner A,
Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU,
Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD,
Radlwimmer B, Scheurlen W, Lichter P, Korshunov A.
Outcome
prediction in pediatric medulloblastoma based on DNA copy-number
aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
J
Clin Oncol. 2009
Mar 2;27(10):1627-36. doi:
10.1200/JCO.2008.17.9432. PMID:
19255330. Laboratory investigation. ˍ
Drummond SR, Kemp EG.
Retinal
astrocytoma managed by brachytherapy.
Ophthalmology.
2009 Mar 3;116(3):597-597.e1. doi:
10.1016/j.ophtha.2008.12.008. PMID:
19264224. Letter, Case report. ˍ
Ohno M, Natsume A, Fujii M, Ito M,
Wakabayashi T.
Interferon-beta,
MCNU, and conventional radiotherapy for pediatric patients with
brainstem glioma.
Pediatr
Blood Cancer.
2009 Mar 3;53(1):37-41. doi:
10.1002/pbc.21987. PMID:
19260101. Observational
study. ˍ
Komotar RJ, Otten ML, Garrett MC,
Anderson RC.
Treatment
of early childhood
medulloblastoma
by postoperative chemotherapy alone-a critical review.
Clin
Med Oncol.
2009 Mar 4;3:13-4. doi:
10.4137/cmo.s392. PMID:
20689605. Comment. ˍ
Related
article:
Rutkowski
S, Bode U, Deinlein F, et al. Treatment of early childhood
medulloblastoma by postoperative chemotherapy alone.
N
Engl J Med.
2005 Mar 10;352(10):978-86. doi:
10.1056/NEJMoa042176. PMID:
15758008. Interventional study. ˍ
Sasportas LS, Kasmieh R, Wakimoto
H, Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL,
Martuza RL, Weissleder R, Shah K.
Assessment
of therapeutic efficacy and fate of engineered human mesenchymal
stem cells for cancer therapy.
Proc
Natl Acad Sci U S A.
2009 Mar 5;106(12):4822-7. doi:
10.1073/pnas.0806647106. PMID:
19264968. Laboratory investigation. ˍ
Northcott PA, Nakahara Y, Wu X,
Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc
A, Ra YS, Zilberberg K, McLeod J, Scherer SW, Sunil Rao J,
Eberhart CG, Grajkowska W, Gillespie Y, Lach B, Grundy R, Pollack
IF, Hamilton RL, Van Meter T, Carlotti CG, Boop F, Bigner D,
Gilbertson RJ, Rutka JT, Taylor MD.
Multiple
recurrent genetic events converge on control of histone lysine
methylation in medulloblastoma.
Nat
Genet. 2009 Mar
8;41(4):465-72. doi:
10.1038/ng.336. PMID:
19270706. Laboratory investigation. ˍ
*Villano JL, Mlinarevich N, Watson
KS, Engelhard HH, Anderson-Shaw L.
Aggression
in a patient with primary brain tumor: ethical implications for
best management.
J
Neurooncol. 2009
Mar 8;94(2):293-6. doi:
10.1007/s11060-009-9850-3. PMID:
19267227. Case report. ˍ
Carrie C, Grill J,
Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel
M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P,
Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart
S.
Online
quality control, hyperfractionated radiotherapy alone and reduced
boost volume for standard risk medulloblastoma: long-term results
of MSFOP 98.
J
Clin Oncol. 2009
Mar 9;27(11):1879-83. doi:
10.1200/JCO.2008.18.6437. PMID:
19273707. Interventional
study. ˍ
Stupp
R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC,
Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA,
Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa
S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG,
Mirimanoff RO; European Organisation for Research and Treatment of
Cancer Brain Tumour and Radiation Oncology Groups; National Cancer
Institute of Canada Clinical Trials Group.
Effects
of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial.
Lancet
Oncol.
2009 Mar 9. 2009;10(5):459-66. doi:
10.1016/S1470-2045(09)70025-7. PMID:
19269895. Interventional study. ˍ
Garrè ML, Cama A, Bagnasco
F, Morana G, Giangaspero F, Brisigotti M, Gambini C, Forni M,
Rossi A, Haupt R, Nozza P, Barra S, Piatelli G, Viglizzo G, Capra
V, Bruno W, Pastorino L, Massimino M, Tumolo M, Fidani P, Dallorso
S, Schumacher RF, Milanaccio C, Pietsch T.
Medulloblastoma
variants: age-dependent occurrence and relation to Gorlin
syndrome--a new clinical perspective.
Clin
Cancer Res. 2009
Mar 10;15(7):2463-71. doi:
10.1158/1078-0432.CCR-08-2023. PMID:
19276247. Observational
study. ˍ
*Tuettenberg J, Grobholz R, Seiz M,
Brockmann MA, Lohr F, Wenz F, Vajkoczy P.
Recurrence
pattern in glioblastoma multiforme patients treated with
anti-angiogenic chemotherapy.
J
Cancer Res Clin Oncol.
2009 Mar 10;135(9):1239-44. doi:
10.1007/s00432-009-0565-9. PMID:
19277712. Observational
study. ˍ
Combs SE, Steck I, Schulz-Ertner D,
Welzel T, Kulozik AE, Behnisch W, Huber PE, Debus J.
Long-term
outcome of high-precision radiotherapy in patients with brain stem
gliomas: results from a difficult-to-treat patient population
using fractionated stereotactic radiotherapy.
Radiother
Oncol. 2009 Mar
11;91(1):60-6. doi:
10.1016/j.radonc.2009.02.012. PMID:
19285356. Observational
study. ˍ
Majós
C, Aguilera C, Alonso J, Julià-Sapé M, Castañer
S, Sánchez JJ, Samitier A, León A, Rovira A, Arús
C.
Proton
MR spectroscopy improves discrimination between tumor and
pseudotumoral lesion in solid brain masses.
AJNR
Am J Neuroradiol.
2009 Mar
11;30(3):544-51. doi:
10.3174/ajnr.A1392. PMID:
19095788. Observational study. ˍ
Yamamoto T, Nakai K, Kageji T,
Kumada H, Endo K, Matsuda M, Shibata Y, Matsumura A.
Boron
neutron capture therapy for newly diagnosed
glioblastoma.
Radiother
Oncol. 2009 Mar
11;91(1):80-4. doi:
10.1016/j.radonc.2009.02.009. PMID:
19285355. Observational
study. ˍ
Katz A, Calabrich A, Dos Santos
Fernandes G, Sakis Novis YA.
Complete
Radiologic Response in an Anaplastic Oligodendroglioma Treated
with Temozolomide and Bevacizumab.
Case
Rep Oncol. 2009
Mar 14;2(1):57-60. doi:
10.1159/000208378. PMID:
20740146. Case report. ˍ
*
Castriconi R, Daga A, Dondero A,
Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R,
Bellora F, Moretta L, Moretta A, Corte G, Bottino C.
NK
cells recognize and kill human glioblastoma cells with stem
cell-like properties.
J
Immunol. 2009 Mar
15;182(6):3530-9∟. doi:
10.4049/jimmunol.0802845. PMID:
19265131. Laboratory investigation. ˍ
Miyatake S, Kawabata S, Nonoguchi
N, Yokoyama K, Kuroiwa T, Matsui H, Ono K.
Pseudoprogression
in boron neutron capture therapy for malignant gliomas and
meningiomas.
Neuro
Oncol. 2009 Mar
16;11(4):430-6. doi:
10.1215/15228517-2008-107. PMID:
19289492. Observational
study. ˍ
Quinn JA, Jiang SX, Reardon DA,
Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH,
Bigner DD, Sampson JH, McLendon RE, Herndon JE Jr, Walker A,
Friedman HS.
Phase
I trial of temozolomide plus O6-benzylguanine 5-day regimen with
recurrent malignant glioma.
Neuro
Oncol. 2009 Mar
16;11(5):556-61. doi:
10.1215/15228517-2009-007. PMID:
19289491. Interventional
study. ˍ
Biswas T, Okunieff P, Schell MC,
Smudzin T, Pilcher WH, Bakos RS, Vates GE, Walter KA, Wensel A,
Korones DN, Milano MT.
Stereotactic
radiosurgery for glioblastoma: retrospective analysis.
Radiat
Oncol. 2009 Mar
17;4:11. doi:
10.1186/1748-717X-4-11. PMID:
19292912. Observational
study. ˍ
Cetica V, Genitori L, Giunti L,
Sanzo M, Bernini G, Massimino M, Sardi I.
Pediatric
brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that
directly repair alkylation damage.
J
Neurooncol. 2009
Mar 17;94(2):195-201. doi:
10.1007/s11060-009-9837-0. PMID:
19290481. Observational
study. ˍ
Miyake JA, Benadiba M, Colquhoun
A.
Gamma-linolenic
acid inhibits both tumour cell cycle progression and angiogenesis
in the orthotopic C6 glioma model through changes in VEGF, Flt1,
ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein
expression.
Lipids
Health Dis. 2009
Mar 17;8:8. doi:
10.1186/1476-511X-8-8. PMID:
19292920. Laboratory investigation. ˍ
Anoop P.
Near
total effacement of bone marrow by medulloblastoma.
Am
J Hematol. 2009
Mar 20;85(2):128. doi:
10.1002/ajh.21410. PMID:
19384932. Case report. ˍ
*Khasraw M, Bell D, Wheeler
H.
Long-term
use of temozolomide: could you use temozolomide safely for life in
gliomas?
J
Clin Neurosci.
2009 Mar 20;16(6):854-5. doi:
10.1016/j.jocn.2008.09.005. PMID:
19303779. Case report. ˍ
Taddei PJ, Mirkovic D, Fontenot JD,
Giebeler A, Zheng Y, Kornguth D, Mohan R, Newhauser WD.
Stray
radiation dose and second cancer risk for a pediatric patient
receiving craniospinal irradiation with proton beams.
Phys
Med Biol. 2009
Mar 20;54(8):2259-75. doi:
10.1088/0031-9155/54/8/001. PMID:
19305045. Case report. ˍ
Armstrong GT, Whitton JA, Gajjar A,
Kun LE, Chow EJ, Stovall M, Leisenring W, Robison LL, Sklar
CA.
Abnormal
timing of menarche in survivors of central nervous system tumors:
A report from the Childhood Cancer Survivor Study.
Cancer.
2009 Mar 23;115(11):2562-70. doi:
10.1002/cncr.24294. PMID:
19309737. Observational
study. ˍ
Galanis E, Jaeckle KA, Maurer MJ,
Reid JM, Ames MM, Hardwick JS, Reilly JF, Loboda A, Nebozhyn M,
Fantin VR, Richon VM, Scheithauer B, Giannini C, Flynn PJ, Moore
DF Jr, Zwiebel J, Buckner JC.
Phase
II trial of vorinostat in recurrent glioblastoma multiforme: a
north central cancer treatment group study.
J
Clin Oncol. 2009
Mar 23;27(12):2052-8. doi:
10.1200/JCO.2008.19.0694. PMID:
19307505. Interventional
study. ˍ
Milano GM, Cerri C, Ferruzzi V,
Capolsini I, Mastrodicasa E, Genitori L, Aversa F.
Congenital
glioblastoma.
Pediatr
Blood Cancer.
2009 Mar 23;53(1):124-6. doi:
10.1002/pbc.22008. PMID:
19309717. Case report. ˍ
Garzia L, Andolfo I, Cusanelli E,
Marino N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas
L, Esposito S, Gargiulo S, Fattet S, Donofrio V, Cinalli G,
Brunetti A, Vecchio LD, Northcott PA, Delattre O, Taylor MD,
Iolascon A, Zollo M.
MicroRNA-199b-5p
impairs cancer stem cells through negative regulation of HES1 in
medulloblastoma.
PLoS
One. 2009 Mar
24;4(3):e4998. doi:
10.1371/journal.pone.0004998. PMID:
19308264. Laboratory investigation. ˍ
Henderson MA, Fakiris AJ, Timmerman
RD, Worth RM, Lo SS, Witt TC.
Gamma
knife stereotactic radiosurgery for low-grade
astrocytomas.
Stereotact
Funct Neurosurg.
2009 Mar 24;87(3):161-7. doi:
10.1159/000209297. PMID:
19321969. Observational
study. ˍ
Matsumura A, Yamamoto T, Tsurubuchi
T, Matsuda M, Shirakawa M, Nakai K, Endo K, Tokuue K, Tsuboi
K.
Current
practices and future directions of therapeutic strategy in
glioblastoma: survival benefit and indication of BNCT.
Appl
Radiat Isot. 2009
Mar 24;67(7-8 Suppl):S12-4. doi:
10.1016/j.apradiso.2009.03.010. PMID:
19375923. Observational
study. ˍ
Yamamoto T, Nakai K, Tsurubuchi T,
Matsuda M, Shirakawa M, Zaboronok A, Endo K, Matsumura A.
Boron
neutron capture therapy for newly diagnosed glioblastoma: a pilot
study in Tsukuba.
Appl
Radiat Isot. 2009
Mar 24;67(7-8 Suppl):S25-6. doi:
10.1016/j.apradiso.2009.03.011. PMID:
19375927. Interventional
study. ˍ
Kawabata S, Miyatake S, Nonoguchi
N, Hiramatsu R, Iida K, Miyata S, Yokoyama K, Doi A, Kuroda Y,
Kuroiwa T, Michiue H, Kumada H, Kirihata M, Imahori Y, Maruhashi
A, Sakurai Y, Suzuki M, Masunaga S, Ono K.
Survival
benefit from boron neutron capture therapy for the newly diagnosed
glioblastoma patients.
Appl
Radiat Isot. 2009
Mar 25;67(7-8 Suppl):S15-8. doi:
10.1016/j.apradiso.2009.03.015. PMID:
19398348. Observational
study. ˍ
Czernicki T, Szeszkowski W, Marchel A, Gołebiowski
M.
Spectral changes in postoperative
MRS in high-grade gliomas and their effect on patient
prognosis.
Folia
Neuropathol. 2009 Mar 26;47(1):43-9. PMID:
19353433. Observational
study. ˍ
Grodman H, Wolfe L, Kretschmar
C.
Outcome
of patients with recurrent medulloblastoma or central nervous
system germinoma treated with low dose continuous intravenous
etoposide along with dose-intensive chemotherapy followed by
autologous hematopoietic stem cell rescue.
Pediatr
Blood Cancer.
2009 Mar 26;53(1):33-6. doi:
10.1002/pbc.21985. PMID:
19326417. Observational
study. ˍ
*Sperduto CM, Chakravarti A, Aldape
K, Burger P, Papermaster GB, Sperduto P.
Twenty-year
survival in glioblastoma: a case report and molecular profile.
Int
J Radiat Oncol Biol Phys.
2009 Mar 26;75(4):1162-5. doi:
10.1016/j.ijrobp.2008.12.054. PMID:
19327897. Case report. ˍ
Matsuda M, Yamamoto T, Kumada H,
Nakai K, Shirakawa M, Tsurubuchi T, Matsumura A.
Dose
distribution and clinical response of glioblastoma treated with
boron neutron capture therapy.
Appl
Radiat Isot. 2009
Mar 27;67(7-8 Suppl):S19-21. doi:
10.1016/j.apradiso.2009.03.054. PMID:
19375933. Observational
study. ˍ
Miyatake S, Kawabata S, Yokoyama K,
Kuroiwa T, Michiue H, Sakurai Y, Kumada H, Suzuki M, Maruhashi A,
Kirihata M, Onoc K.
Survival
benefit of boron neutron capture therapy for recurrent malignant
gliomas.
Appl
Radiat Isot. 2009
Mar 27;67(7-8 Suppl):S22-4. doi:
10.1016/j.apradiso.2009.03.032. PMID:
19394240. Observational
study. ˍ
Spence AM, Muzi M, Link JM,
O'Sullivan F, Eary JF, Hoffman JM, Shankar LK, Krohn
KA.
NCI-sponsored
trial for the evaluation of safety and preliminary efficacy of
3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of
proliferation in patients with recurrent gliomas: preliminary
efficacy studies.
Mol
Imaging Biol.
2009 Mar 27;11(5):343-55. doi:
10.1007/s11307-009-0215-2. PMID:
19326172. Interventional
study. ˍ
Kita D, Ciernik IF, Vaccarella S,
Franceschi S, Kleihues P, Lütolf UM, Ohgaki H.
Age
as a predictive factor in glioblastomas: population-based
study.
Neuroepidemiology.
2009 Mar 27;33(1):17-22. doi:
10.1159/000210017. PMID:
19325245. Observational
study. ˍ
Nakagawa Y, Kageji T, Mizobuchi Y,
Kumada H, Nakagawa Y.
Clinical
results of BNCT for malignant brain tumors in children.
Appl
Radiat Isot. 2009
Mar 28;67(7-8 Suppl):S27-30. doi:
10.1016/j.apradiso.2009.03.090. PMID:
19406652. Observational
study. ˍ
*Pouratian N, Crowley RW, Sherman
JH, Jagannathan J, Sheehan JP.
Gamma
Knife radiosurgery after radiation therapy as an adjunctive
treatment for glioblastoma.
J
Neurooncol. 2009
Mar 29;94(3):409-18. doi:
10.1007/s11060-009-9873-9. PMID:
19330482. Observational
study. ˍ
Russell SM, Elliott R, Forshaw D,
Golfinos JG, Nelson PK, Kelly PJ.
Glioma
vascularity correlates with reduced patient survival and increased
malignancy.
Surg
Neurol. 2009 Mar
29;72(3):242-6. doi:
10.1016/j.surneu.2008.11.012. PMID:
19329156. Observational
study. ˍ
Schiff D, Kline C, Meltzer H, Auger
J.
Palliative
ventriculoperitoneal shunt in a pediatric patient with recurrent
metastatic medulloblastoma.
J
Palliat Med. 2009
Mar 29;12(4):391-3. doi:
10.1089/jpm.2008.0227. PMID:
19327082. Case report. ˍ
*Kozak KR, Moody JS.
Giant
cell glioblastoma: a glioblastoma subtype with distinct
epidemiology and superior prognosis.
Neuro
Oncol. 2009 Mar
30;11(6):833-41. doi:
10.1215/15228517-2008-123. PMID:
19332771. Observational
study. ˍ
*Quant EC, Norden AD, Drappatz J,
Muzikansky A, Doherty L, Lafrankie D, Ciampa A, Kesari S, Wen
PY.
Role
of a second chemotherapy in recurrent malignant glioma patients
who progress on bevacizumab.
Neuro
Oncol. 2009 Mar
30;11(5):550-5. doi:
10.1215/15228517-2009-006. PMID:
19332770. Observational
study. ˍ
Fabi A, Metro G, Russillo M, Vidiri
A, Carapella CM, Maschio M, Cognetti F, Jandolo B, Mirri MA,
Sperduti I, Telera S, Carosi M, Pace A.
Treatment
of recurrent malignant gliomas with fotemustine monotherapy:
impact of dose and correlation with MGMT promoter methylation.
BMC
Cancer. 2009 Mar
31;9:101. doi:
10.1186/1471-2407-9-101. PMID:
19335893. Observational
study. ˍ